Related Experiment Video
Updated: Jul 3, 2026
06:46
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Colon cancer: update on adjuvant therapy
1Medical Oncology Unit, Cliniques Universitaires Saint Luc, Université Catholique de Louvain, Brussels, Belgium. max.mano@gmail.com
Clinical Colorectal Cancer
|July 16, 2008
Summary
Colon cancer remains a global health challenge. Research focuses on improving early detection, prevention, and adjuvant treatments like oxaliplatin chemotherapy, especially for advanced stages and elderly patients.
Area of Science:
- Oncology
- Public Health
Background:
- Colon cancer is a significant worldwide health issue.
- Metastatic disease is often incurable, despite early-stage curability.
- Recurrence rates for resected stage II/III colon cancer exceed 20%.
Purpose of the Study:
- To review current strategies for colon cancer management.
- To discuss the role of adjuvant chemotherapy, including oxaliplatin and oral fluoropyrimidines.
- To highlight challenges in treating elderly patients and explore novel biologic agents.
Main Methods:
- Review of current literature and clinical practices in colon cancer treatment.
- Discussion of standard-of-care chemotherapy regimens.
- Exploration of emerging therapeutic approaches.
Main Results:
- Oxaliplatin-based chemotherapy is standard for node-positive colon cancer.
- Oral fluoropyrimidines are an alternative to 5-fluorouracil.
- Elderly patients may benefit from chemotherapy, but treatment can be challenging.
Conclusions:
- Adjuvant treatment for node-negative colon cancer requires further clarification.
- Challenges exist in treating elderly colon cancer patients.
- Biologic agents show promise for adjuvant therapy in colon cancer.
Related Concept Videos
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...